AnaptysBio, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 26.41 million compared to USD 32.54 million a year ago. Basic loss per share from continuing operations was USD 0.93 compared to USD 1.18 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.91 USD | -4.21% | -4.63% | +11.62% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.62% | 65Cr | |
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.34TCr | |
-1.69% | 2.18TCr | |
-10.60% | 1.81TCr | |
-41.25% | 1.67TCr | |
-15.33% | 1.6TCr | |
+5.80% | 1.4TCr | |
+28.03% | 1.17TCr |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022